FAQ
Użytkownicy
Grupy
Galerie
Rejestracja
Zaloguj
Profil
Zaloguj się, by sprawdzić wiadomości
Szukaj
Forum Strona Główna
->
Osiem szczytów
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
TAK
BBCode
:
TAK
Uśmieszki:
NIE
Wyłącz HTML w tym poście
Wyłącz BBCode w tym poście
Kod potwierdzający: *
Wszystkie czasy w strefie EET (Europa)
Skocz do:
Wybierz forum
Biblioteki Kreatorów
----------------
Księga Zasad
Księga Postaci
Księga Potworów i Bohaterów Niezależnych
FAQ
Miasto: Eriopolis
----------------
Dzielnica Portowa (północna)
Dzielnica Handlowa (wschodnia)
Dzielnica Wyższa (zachodnia)
Dzielnica Niższa (południowa)
Kanały pod Miastem
Okolice Miasta
Dzika Puszcza
----------------
Czarny Las
Wioska Bastai
Wzgórza i Góry
----------------
Las w cieniu Gór
Wzgórza
Zbocze
Chmurne Szczyty
Równina Mgieł
----------------
Wiśniowa Wioska
Stepy
Miasto: Arion
----------------
Arion (epidemia)
Wioska Pravium
Okolice Miasta Arion
Ocean Wiatrów
----------------
Szlaki Handlowe
Wyspa Rukia
Wyspa Piratów
Wyspa Kei-Sumi
W podróży
----------------
Tabor
Cyrk
Pustkowia
----------------
Bagna
Ruiny
Osiem szczytów
Wielkie lasy
Przegląd tematu
Autor
Wiadomość
05c71gln62jh
Wysłany: Pią 9:00, 11 Lut 2011
Temat postu: WuXi PharmaTech Well Positioned to Continue Growin
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that its previously announced transaction with Charles River Laboratories International Inc. (NYSE: CRL) has been terminated by mutual agreement due to Charles River shareholder opposition. Under the terms of the termination agreement,
hospitality solution
, WuXi will receive a breakup fee of $30 million.
"WuXi‘s strategy has not changed. Our goal is, and has long been,
Data convention outsourcing
, to build a broad,
healthcare outsourcing
, integrated R&D service platform designed to help our customers improve the success of research and shorten the time of new product development," said Dr. Ge Li, Chairman and Chief Executive Officer. "While we are disappointed that this transaction could not be completed,
Business process outsourcing
, WuXi remains well positioned to meet our customers‘ needs and to continue to grow and expand as a standalone company.
"All of our businesses are performing very well," Dr. Li continued. "Each business unit has met or exceeded its targets for the second quarter, and we recently increased our guidance for full-year 2010 financial performance.
"Virtually all of the large global pharmaceutical companies, as well as hundreds of smaller pharmaceutical and biotech companies and many leading medical device companies, are our customers,
health care outsourcing
," Dr. Li concluded. "We believe that strong trends for greater outsourcing and offshoring of R&D services will continue, and that WuXi, as the leading China-based contract research organization, is well positioned to benefit from this powerful outsourcing trend for many years to come."
Second Quarter Results
WuXi will report financial results for the second quarter ending June 30, 2010, on Monday, August 2, at 6:30 am EDT with a conference call at 8:30 am EDT to discuss the results and the outlook for WuXi‘s business. The conference call may be accessed by calling:
United States: 1-866-519-4004
China (Landline): 800-819-0121
China (Mobile): 400-620-8038
Hong Kong: 800-930-346
United Kingdom: 0-808-234-6646
International: +65-6723-9381
Conference ID: 90840146
Web PIN: 8656
A replay will be available two hours after the call‘s completion at:
United States: 1-866-214-5335
China North: 10-800-714-0386
China South: 10-800-140-0386
Hong Kong: 800-901-596
United Kingdom: 0-800-731-7846
International: +61-2-8235-5000
Passcode: 90840146
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech‘s website at .
fora.pl
- załóż własne forum dyskusyjne za darmo
Elveron phpBB theme/template by
Ulf Frisk
and
Michael Schaeffer
Copyright Š Ulf Frisk, Michael Schaeffer 2004
Powered by
phpBB
© 2001, 2002 phpBB Group
Regulamin